Your browser doesn't support javascript.
loading
Impact of the COVID-19 pandemic on head and neck cancer diagnosis: data from a single referral center, South Tyrol, northern Italy.
Gazzini, Luca; Fazio, Enrico; Dallari, Virginia; Accorona, Remo; Abousiam, Monir; Nebiaj, Aurel; Giorgetti, Giovanni; Girolami, Ilaria; Vittadello, Fabio; Magnato, Roberto; Patscheider, Martin; Mazzoleni, Guido; Calabrese, Luca.
Afiliação
  • Gazzini L; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
  • Fazio E; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
  • Dallari V; Division of Otorhinolaryngology, Department of Surgery, Dentistry, Gynecology, and Pediatrics, University Hospital of Verona, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy. virginia.dallari@gmail.com.
  • Accorona R; Department of Otorhinolaryngology, Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Abousiam M; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
  • Nebiaj A; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
  • Giorgetti G; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
  • Girolami I; Division of Pathological Anatomy, "San Maurizio" Hospital, Bolzano, Italy.
  • Vittadello F; Division of Pathological Anatomy, "San Maurizio" Hospital, Bolzano, Italy.
  • Magnato R; Division of Otorhinolaryngology, "Franz Tappeiner" Hospital, Merano, Italy.
  • Patscheider M; Division of Otorhinolaryngology, Bressanone Hospital, Bressanone, Italy.
  • Mazzoleni G; Division of Pathological Anatomy, "San Maurizio" Hospital, Bolzano, Italy.
  • Calabrese L; Division of Otorhinolaryngology, "San Maurizio" Hospital, Bolzano, Italy.
Eur Arch Otorhinolaryngol ; 279(6): 3159-3166, 2022 Jun.
Article em En | MEDLINE | ID: mdl-34739577
ABSTRACT

OBJECTIVE:

The aim of the study was to evaluate the impact of the COVID-19 pandemic on new diagnoses of head and neck cancer (HNC) in South Tyrol, northern Italy in terms of the number of new diagnoses and worsening disease stage due to diagnostic delay.

METHODS:

Patients were divided into two groups the control group with a first diagnosis of HNC in 10 months before the national lockdown (March 9th, 2020) and the study group with a first diagnosis of HNC in 10 months after lockdown.

RESULTS:

A total of 124 patients were included in the study. Before the spread of COVID-19, 79 new diagnoses of HNCs were registered, while in the period after the lockdown, 45 new cancers cases were diagnosed and the difference was statistically significant (p = 0.01278). Early clinical T-stage results showed 52 cases in the control group and 21 in the study group, again with a significant difference (p = 0.03711). Advanced T-stage results showed 27 cases in the control group and 24 in the study group.

CONCLUSIONS:

This study highlights the impact of the COVID-19 pandemic on HNCs, showing a statistically significant difference in the number of diagnoses before and after the lockdown which was related to the spread of the SARS-CoV-2 virus, and with a relevant decrease in early cT-staged HNCs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2022 Tipo de documento: Article